Literature DB >> 3243327

Stereoselectivity, a natural aspect of molecular biology: a blind spot in clinical pharmacology and pharmacokinetics.

E J Ariëns.   

Abstract

Mesh：

Year:  1988        PMID： 3243327     DOI： 10.1007/BF03190095

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN： 0378-7966            Impact factor:   2.441


× No keyword cloud information.
  5 in total

Review 1.  Stereoselectivity of bioactive xenobiotics. A pre-Pasteur attitude in medicinal chemistry, pharmacokinetics and clinical pharmacology.

Authors:  E J Ariëns; E W Wuis; E J Veringa
Journal:  Biochem Pharmacol       Date:  1988-01-01       Impact factor: 5.858

2.  Bias in pharmacokinetics and clinical pharmacology.

Authors:  E J Ariëns; E W Wuis
Journal:  Clin Pharmacol Ther       Date:  1987-10       Impact factor: 6.875

3.  Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: an overview.

Authors:  D E Drayer
Journal:  Clin Pharmacol Ther       Date:  1986-08       Impact factor: 6.875

Review 4.  Implications of the neglect of stereochemistry in pharmacokinetics and clinical pharmacology.

Authors:  E J Ariëns
Journal:  Drug Intell Clin Pharm       Date:  1987-10

5.  Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology.

Authors:  E J Ariëns
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953
  5 in total
  1 in total

1.  Potential errors in the volume of distribution estimation of therapeutic proteins composed of differently cleared components.

Authors:  Wolfgang F Richter; Hans Peter Grimm; Frank-Peter Theil
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-07-21       Impact factor: 2.745
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.